Genotropin Enhances Bone Density in American Males with GHD and Osteopenia: 5-Year Study
Reading Time: 2 minutesIntroduction Osteopenia, a condition characterized by lower bone mineral density than normal, poses a significant health risk, particularly among American males with growth hormone deficiency (GHD). The management of osteopenia in this demographic is crucial to prevent progression to osteoporosis and subsequent fractures. Genotropin, a recombinant human growth hormone, has been a subject of interest in the medical community for... Read more »
